Titre : | Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence |
Titre traduit : | (Obstacles et facilités aux soins de premier recours ou au traitement du virus de l'immunodéficience humaine proposant la méthadone ou la buprénorphine pour la gestion de la dépendance aux opiacés) |
Auteurs : | B. J. TURNER ; C. LAINE ; Y. T. LIN ; K. LYNCH |
Type de document : | Périodique |
Année de publication : | 2006 |
Format : | 1769-1776 |
Note générale : |
Archives of Internal Medicine, 2006, 165, (15), 1769-1776 |
Langues: | Français |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés VIH ; METHADONE ; BUPRENORPHINE ; OPIACES ; DEPENDANCE ; TRAITEMENT DE MAINTENANCE ; TRAITEMENT ; ENQUETEThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : BACKGROUND: Federal initiatives aim to increase office-based treatment of opioid dependence, but, to our knowledge, factors associated with willingness to deliver this care have not been defined. The objective of this study was to describe clinics' willingness to provide methadone hydrochloride or buprenorphine hydrochloride for opioid dependence. METHODS: The design of the study was a survey conducted in New York State. Two hundred sixty-one directors of primary care and/or human immunodeficiency virus specialty clinics (response rate, 61.1%) that serve Medicaid enrollees were questioned. Outcomes were willingness to provide methadone and buprenorphine. Predictors included clinic characteristics, attitudes about drug users and their treatment, and reported barriers and facilitators to treatment. RESULTS: Clinics were more willing to provide buprenorphine than methadone treatment (59.8% vs 32.6%; P |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 54 |
Affiliation : |
Division of General Internal Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021. Email : bturner@mail.med.upenn.edu Etats-Unis. United States. |
Numéro Toxibase : | 1301783 |
Centre Emetteur : | 13 OFDT |
Cote : | A02804 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil